TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26964733

Group type: EXPERIMENTAL
Intervention: GnRHa for 2 years
Number of subjects: 76

Group type: COMPARATOR
Intervention: GH only
Number of subjects: 76
Study: 24884563

Group type: EXPERIMENTAL
Intervention: Care Dependency Scale (CDS) assessment at baseline, 6 months, and 12 months
Number of subjects: 890
Study: 22648843

Group type: EXPERIMENTAL
Intervention: Microbiological and immunological enteral nutrition (probiotics, glutamine, fish oil)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Routine enteral nutrition
Number of subjects: 67
Study: 19956970

Group type: EXPERIMENTAL
Intervention: Creatine supplementation (CrS)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (Pl)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Creatine supplementation (CrS) in rats
Number of subjects: 8
Study: 19102241

Group type: EXPERIMENTAL
Intervention: Anesthetic modes and reflex exposures in the complex therapy
Number of subjects: 484

Group type: EXPERIMENTAL
Intervention: Medicinal blocks
Number of subjects: 484

Group type: EXPERIMENTAL
Intervention: Anesthetic modes and reflex exposures
Number of subjects: 484

Group type: COMPARATOR
Intervention: Conventional complex therapy (control group)
Number of subjects: 484
Study: 16078205

Group type: EXPERIMENTAL
Intervention: Levetiracetam (add-on therapy, starting dose of 500 mg twice per day up to 50 mg/kg/day)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Levetiracetam
Number of subjects: 16
Study: 11796385

Group type: EXPERIMENTAL
Intervention: Levofloxacin 500 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Levofloxacin 750 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Monte Carlo simulation
Number of subjects: 0
Study: 10959316

Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 744

Group type: COMPARATOR
Intervention: Control (not treated with clozapine)
Number of subjects: 744
Study: 7566945

Group type: EXPERIMENTAL
Intervention: Acenocoumarol treatment for at least 2 years (duration of treatment: 75.0 ± 52 months)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (not treated by anticoagulant)
Number of subjects: 45
Study: 2255215

Group type: EXPERIMENTAL
Intervention: Transdermal nicotine patch (Nicolan)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 0
Study: 348615

Group type: EXPERIMENTAL
Intervention: Mitomycin C, 0.8 mg/kg body weight intravenously, twice a week for 5 weeks after surgery
Number of subjects: 496

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 496
Study: 31014975

Group type: EXPERIMENTAL
Intervention: Patients identifying medications by name (brand name: 50%; generic: 21%)
Number of subjects: 768

Group type: COMPARATOR
Intervention: Physicians' perception of patient identification
Number of subjects: 768

Group type: COMPARATOR
Intervention: Pharmacists' perception of patient identification
Number of subjects: 768
Study: 28341062

Group type: EXPERIMENTAL
Intervention: Post-mastectomy radiation therapy (PMRT)
Number of subjects: 1649
Study: 26144908

Group type: EXPERIMENTAL
Intervention: Teriparatide to Denosumab
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Denosumab to Teriparatide
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Combination to Denosumab
Number of subjects: 94
Study: 23633195

Group type: EXPERIMENTAL
Intervention: 3-month combined aerobic and resistance exercise program
Number of subjects: 0
Study: 21634303

Group type: EXPERIMENTAL
Intervention: Quercetin supplementation (1 g/day for 6 weeks)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 19162568

Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin (DHA) injectable powder 40mg
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin (DHA) injectable powder 80mg
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin (DHA) injectable powder 160mg
Number of subjects: 3
Study: 17272357

Group type: EXPERIMENTAL
Intervention: 150 mg/day clopidogrel
Number of subjects: 60

Group type: COMPARATOR
Intervention: 75 mg/day clopidogrel
Number of subjects: 60
Study: 15133336

Group type: EXPERIMENTAL
Intervention: Swiss Lithoclast (SLC)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Electrokinetic lithotripter (EKL)
Number of subjects: 38
Study: 11742194

Group type: EXPERIMENTAL
Intervention: Esomeprazole 20 mg + amoxicillin 1 g + clarithromycin 500 mg (EAC)
Number of subjects: 446

Group type: COMPARATOR
Intervention: Omeprazole 20 mg + amoxicillin 1 g + clarithromycin 500 mg (OAC)
Number of subjects: 446
Study: 9580087

Group type: EXPERIMENTAL
Intervention: Meropenem (1 g/8 h)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Ceftazidime (2 g/8 h) plus Amikacin (15 mg/kg/day)
Number of subjects: 93
Study: 8220197

Group type: EXPERIMENTAL
Intervention: Therapeutic touch (back rub)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Back rub without therapeutic touch
Number of subjects: 105
Study: 3315775

Group type: EXPERIMENTAL
Intervention: Oral ribavirin (800-1600 mg/day for 7 days)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 28029069

Group type: EXPERIMENTAL
Intervention: Osteopathic manipulative treatment
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Osteopathy in the cranial field
Number of subjects: 40

Group type: COMPARATOR
Intervention: Both groups combined
Number of subjects: 40
Study: 26059103

Group type: EXPERIMENTAL
Intervention: Prophylactic administration of 70 mg/kg bovine surfactant within 30 minutes after birth
Number of subjects: 207

Group type: COMPARATOR
Intervention: Early treatment with surfactant therapy for established RDS
Number of subjects: 207
Study: 24332485

Group type: EXPERIMENTAL
Intervention: Field-in-field (FIF) technique
Number of subjects: 89

Group type: COMPARATOR
Intervention: Wedged beams (WB) technique
Number of subjects: 89

Group type: COMPARATOR
Intervention: Comparison of FIF and WB techniques
Number of subjects: 89
Study: 24032191

Group type: EXPERIMENTAL
Intervention: Abdominal acupuncture therapy
Number of subjects: 30
Study: 20447648

Group type: EXPERIMENTAL
Intervention: Parent-centered dietary program (Diet)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Child-centered physical activity program (Activity)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Combination of both (Diet + Activity)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Activity (Control)
Number of subjects: 165
Study: 19068673

Group type: EXPERIMENTAL
Intervention: Securebox
Number of subjects: 800

Group type: COMPARATOR
Intervention: Traditional method
Number of subjects: 800
Study: 15856507

Group type: EXPERIMENTAL
Intervention: Diffuse reflectance spectroscopy
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Corrected autofluorescence spectroscopy
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Raw autofluorescence spectroscopy
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Combined autofluorescence and diffuse reflectance spectroscopy
Number of subjects: 242
Study: 12531912

Group type: EXPERIMENTAL
Intervention: He-O2 breathing
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Inspired CO2 breathing
Number of subjects: 12

Group type: COMPARATOR
Intervention: Room air
Number of subjects: 12
Study: 10377079

Group type: EXPERIMENTAL
Intervention: Primary stent placement
Number of subjects: 254

Group type: COMPARATOR
Intervention: Primary angioplasty followed by selective stent placement
Number of subjects: 254
Study: 8670314

Group type: EXPERIMENTAL
Intervention: cA2 (10 mg/kg)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: cA2 (20 mg/kg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 2070884

Group type: EXPERIMENTAL
Intervention: Feeder vessel photocoagulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Scatter photocoagulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 360 degrees of peripheral circumferential treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Feeder vessel treatment
Number of subjects: 0
Study: 6418191

Group type: EXPERIMENTAL
Intervention: Fentanyl 1.5 micrograms kg‐1
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Alfentanil 8, 12 or 16 micrograms kg‐1
Number of subjects: 100

Group type: COMPARATOR
Intervention: No analgesic supplementation
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Fentanyl and Alfentanil (all doses)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Alfentanil (larger doses)
Number of subjects: 100
Study: 31958280

Group type: EXPERIMENTAL
Intervention: MTX 10 mg subcutaneously (s.c.) weekly, starting 2 weeks before adalimumab (W-2) and continuing weekly thereafter.
Number of subjects: 110

Group type: COMPARATOR
Intervention: Not applicable (control group without MTX).
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: MTX 10 mg s.c. weekly (MTX+).
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: MTX co-treatment >W26.
Number of subjects: 110

Group type: COMPARATOR
Intervention: No MTX or ≤W26.
Number of subjects: 110
Study: 31408343

Group type: EXPERIMENTAL
Intervention: Multiconfiguration Time‐Dependent Hartree method using two potential surfaces for calculations.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Two potential energy surfaces used in calculations.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Theoretical approach compared with experimental observations.
Number of subjects: 0
Study: 28434475

Group type: EXPERIMENTAL
Intervention: Music intervention (30 minutes)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Routine nursing care
Number of subjects: 100
Study: 25791092

Group type: EXPERIMENTAL
Intervention: Packer's composite score
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patient Journey score
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: A‐HeFT composite score
Number of subjects: 0
Study: 23296186

Group type: EXPERIMENTAL
Intervention: dextroamphetamine (dAMPH) infusion (0.3mg/kg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: baseline dopamine D2/3 receptor availability with [(123)I]IBZM SPECT
Number of subjects: 12
Study: 21788428

Group type: EXPERIMENTAL
Intervention: 0.75 μg LPS/kg BW (L75)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 1.50 μg LPS/kg BW (L150)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (0 μg LPS/kg BW)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: LPS (0.75 μg and 1.50 μg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: High-CP diet
Number of subjects: 30
Study: 19602473

Group type: EXPERIMENTAL
Intervention: Intracranial pressure (ICP) targeted therapy
Number of subjects: 48
Study: 16696859

Group type: EXPERIMENTAL
Intervention: Pegylated interferon alpha-2b and ribavirin (48 weeks treatment)
Number of subjects: 152
Study: 15548142

Group type: EXPERIMENTAL
Intervention: Low-dose acetylsalicylic acid (ASA) 0.5 mg/kg/day
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 11512248

Group type: EXPERIMENTAL
Intervention: Corneal photographs analyzed at 100 x magnification
Number of subjects: 12
Study: 9415369

Group type: EXPERIMENTAL
Intervention: Surrounding each word with digits or Greek letters
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Surrounding each word with randomly chosen letters, while preserving spaces
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Removing spaces from text with Latin-letter fillers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Filler types (Latin letters, Greek letters, digits, shaded boxes)
Number of subjects: 0
Study: 7706601

Group type: EXPERIMENTAL
Intervention: LCP and cholesterol enriched formula
Number of subjects: 59

Group type: COMPARATOR
Intervention: Standard infant formula
Number of subjects: 59

Group type: COMPARATOR
Intervention: Breastfed infants
Number of subjects: 59
Study: 3300276

Group type: COMPARATOR
Intervention: Chemotherapy (CT)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Chemotherapy (CT) plus liver directed radiotherapy (RT)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Less than full RT doses
Number of subjects: 90
Study: 28272294

Group type: EXPERIMENTAL
Intervention: Nurse/physician interdisciplinary team training in a simulation center
Number of subjects: 0
Study: 31885755

Group type: EXPERIMENTAL
Intervention: Moxibustion combined with methotrexate or leflunomide
Number of subjects: 46

Group type: COMPARATOR
Intervention: Methotrexate or leflunomide (Control)
Number of subjects: 46
Study: 26951335

Group type: EXPERIMENTAL
Intervention: Sumatriptan
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 25527400

Group type: EXPERIMENTAL
Intervention: Attentional Bias Modification (ABM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo task (Control)
Number of subjects: 0
Study: 23179507

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural play therapy (not performed)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham play therapy
Number of subjects: 30
Study: 21531091

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 18212498

Group type: EXPERIMENTAL
Intervention: Intravenous iron sucrose (Venofer(R), 100 mg iron, twice a week for 8 weeks, then once a week for another 4 weeks)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Oral ferrous succinate (200 mg t.i.d. for 12 weeks)
Number of subjects: 136
Study: 16314019

Group type: EXPERIMENTAL
Intervention: Sleep Deprivation
Number of subjects: 12
Study: 14572429

Group type: EXPERIMENTAL
Intervention: Outreach intervention (tailored letters and motivational telephone interviews)
Number of subjects: 501

Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 501
Study: 10735703

Group type: EXPERIMENTAL
Intervention: Heparin-bonded CPB
Number of subjects: 34

Group type: COMPARATOR
Intervention: Non-heparin-bonded CPB
Number of subjects: 34
Study: 9187454

Group type: EXPERIMENTAL
Intervention: Scrubbing for three minutes
Number of subjects: 25

Group type: COMPARATOR
Intervention: Scrubbing for two minutes
Number of subjects: 25
Study: 1286498

Group type: EXPERIMENTAL
Intervention: Flumazenil (mean dose, 0.76 mg)
Number of subjects: 197

Group type: COMPARATOR
Intervention: Placebo (mean dose, 8.9 ml)
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Flumazenil
Number of subjects: 197

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 197
Study: 3994880

Group type: EXPERIMENTAL
Intervention: Halothane
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Enflurane
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 60
Study: 31627715

Group type: EXPERIMENTAL
Intervention: Massive Haemorrhage protocol including systematic early administration of tranexamic acid (TXA)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Standard care before the implementation of the Massive Haemorrhage protocol
Number of subjects: 116
Study: 30100374

Group type: EXPERIMENTAL
Intervention: CIK cell infusion
Number of subjects: 6
Study: 27434703

Group type: EXPERIMENTAL
Intervention: Tennis-serving protocol until the onset of fatigue (defined as a rating of 15 on the Borg Scale and reaching a heart rate of 70% of maximum)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Rest (control group)
Number of subjects: 20
Study: 25409678

Group type: EXPERIMENTAL
Intervention: Citrate 4% catheter lock solution
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unfractionated heparin at a concentration of 5,000 IU/mL
Number of subjects: 0
Study: 22124453

Group type: EXPERIMENTAL
Intervention: Fabuless (structured lipid emulsion)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control fat
Number of subjects: 24
Study: 21066885

Group type: EXPERIMENTAL
Intervention: Combined treatment group (CTG) with Shenmai Injection (SMI) and enteral nutrition
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Combined treatment group (CTG)
Number of subjects: 58
Study: 17885694

Group type: EXPERIMENTAL
Intervention: Nocturnal oxygen therapy
Number of subjects: 543

Group type: COMPARATOR
Intervention: Room air breathing
Number of subjects: 543
Study: 15613582

Group type: EXPERIMENTAL
Intervention: DTO and phenobarbital
Number of subjects: 32

Group type: COMPARATOR
Intervention: DTO alone
Number of subjects: 32
Study: 12163718

Group type: EXPERIMENTAL
Intervention: Allograft bone (fresh-frozen femoral head)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Autograft bone (harvested from the iliac crest)
Number of subjects: 69
Study: 9894538

Group type: COMPARATOR
Intervention: Cage rearing system
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Cage-less system with young hens and fresh bedding material
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Cage-less system with older hens and old bedding material
Number of subjects: 34
Study: 7788195

Group type: EXPERIMENTAL
Intervention: 10 ml of saline
Number of subjects: 300

Group type: COMPARATOR
Intervention: 5 ml of saline
Number of subjects: 300

Group type: COMPARATOR
Intervention: No saline
Number of subjects: 300
Study: 2220578

Group type: EXPERIMENTAL
Intervention: Bepridil (300 to 500 mg/day)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Diltiazem (180 to 300 mg/day)
Number of subjects: 87
Study: 300825

Group type: EXPERIMENTAL
Intervention: Systemic antibiotics before and after the operation
Number of subjects: 904

Group type: COMPARATOR
Intervention: No prophylactic systemic antibiotics
Number of subjects: 904
Study: 31286172

Group type: COMPARATOR
Intervention: Arm cycling (ARM)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Leg cycling (LEG)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Arm and leg cycling (A&L)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Quiet sitting (CTRL)
Number of subjects: 14
Study: 28108978

Group type: EXPERIMENTAL
Intervention: Short-course intravenous levofloxacin (750 mg/day for 5 days)
Number of subjects: 317

Group type: COMPARATOR
Intervention: Conventional intravenous/oral levofloxacin (500 mg/day for 7-14 days)
Number of subjects: 317

Group type: EXPERIMENTAL
Intervention: Short-course intravenous levofloxacin (750 mg/day)
Number of subjects: 317

Group type: COMPARATOR
Intervention: Conventional intravenous/oral levofloxacin (500 mg/day)
Number of subjects: 317
Study: 25040296

Group type: EXPERIMENTAL
Intervention: Pulsed dye laser (PDL) treatment (wavelength 595 nm; fluence 8 J cm(‐2); pulse duration 0.5 ms; spot size 10 mm)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Pulsed dye laser (PDL) treatment
Number of subjects: 39
Study: 24035402

Group type: EXPERIMENTAL
Intervention: Computer-assisted cognitive remediation therapy (CACR)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Active control condition
Number of subjects: 67
Study: 20427547

Group type: EXPERIMENTAL
Intervention: Multidimensional Family Therapy-Detention to Community (MDFT-DTC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 19928509

Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine (IVL) 3 mg x kg(‐1) for 30 min
Number of subjects: 43

Group type: COMPARATOR
Intervention: Saline 100 ml for 30 min
Number of subjects: 43
Study: 17703241

Group type: EXPERIMENTAL
Intervention: Budesonide-formoterol as maintenance and reliever treatment
Number of subjects: 2143

Group type: COMPARATOR
Intervention: Salmeterol-fluticasone as maintenance medication plus salbutamol as needed
Number of subjects: 2143
Study: 14718489

Group type: EXPERIMENTAL
Intervention: Intramuscular testosterone (200 mg every 3 weeks)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 12761015

Group type: EXPERIMENTAL
Intervention: 2-mL volume of epidural fentanyl
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 10-mL volume of epidural fentanyl
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 20-mL volume of epidural fentanyl
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: All groups (2-mL, 10-mL, 20-mL)
Number of subjects: 60
Study: 10465993

Group type: EXPERIMENTAL
Intervention: Ethanol dependent patients with respiratory symptoms (Group I)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Ethanol dependent patients without respiratory symptoms (Group II)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Healthy subjects (Control group)
Number of subjects: 124
Study: 7782978

Group type: EXPERIMENTAL
Intervention: Intensive oral hygiene training program with detailed information, self-diagnosis training, and ongoing motivation.
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Shorter oral hygiene training program without motivation and feedback.
Number of subjects: 227

Group type: COMPARATOR
Intervention: Control group with no motivation sessions or oral hygiene training.
Number of subjects: 227
Study: 2194971

Group type: EXPERIMENTAL
Intervention: pivampicillin/pivmecillinam
Number of subjects: 36

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 36
Study: 488428

Group type: COMPARATOR
Intervention: 50 mg progesterone injection
Number of subjects: 0
Study: 31182338

Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg/day
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Glimepiride 2 mg/day
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 28739319

Group type: EXPERIMENTAL
Intervention: Dietary advice pamphlet
Number of subjects: 70

Group type: COMPARATOR
Intervention: Care and maintenance advice for dentures
Number of subjects: 70
Study: 24845394

Group type: EXPERIMENTAL
Intervention: 5 mg of transdermal testosterone cream (TTC)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: 10 mg of transdermal testosterone cream (TTC)
Number of subjects: 7
Study: 23623952

Group type: EXPERIMENTAL
Intervention: Positive Psychotherapy (PPT) group (n=16)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (n=18)
Number of subjects: 34
Study: 22171999

Group type: COMPARATOR
Intervention: Essential oil mouthwash with alcohol (control)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Essential oil mouthwash without alcohol (test)
Number of subjects: 30
Study: 19443520

Group type: EXPERIMENTAL
Intervention: Dry powder inhalers (DPIs)
Number of subjects: 15
Study: 17441983

Group type: EXPERIMENTAL
Intervention: Astra Tech Single Tooth Implant (ST) with Microthread
Number of subjects: 17

Group type: COMPARATOR
Intervention: Astra Tech TiOblast Implant (TB) without Microthread
Number of subjects: 17
Study: 15197140

Group type: EXPERIMENTAL
Intervention: Repaglinide (1.5 to 12 mg/d)
Number of subjects: 175

Group type: COMPARATOR
Intervention: Glyburide (5 to 20 mg/d)
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Repaglinide
Number of subjects: 175

Group type: COMPARATOR
Intervention: Glyburide
Number of subjects: 175